IDIX (Idenix Pharmaceut)
All Pro Portfolios with IDIX
All Do-It-Yourself Portfolios with IDIX
- Total Do-It-Yourself Portfolios with IDIX:
- Jim G.'s PSYCLE sm, late Sept. '06
- Adam Wolfson Portfolio 1
- Kennon
- Clear Spin-off Index
- TWEVER Portfolio 1
- fed1
- Ferrengi Holdings
- brianlushing Portfolio 1
- ste v d
- susejg Portfolio 1
- vladys buttom fishing
- SoloRolo Portfolio 1
- Long Term Stock Picks by Corey Schier
- show more
- 25
- Hepatitis C Stocks
- Quantum Trading Low Priced
- DAMJAN Portfolio 1
- Jim's "PSYCLE sm" Portfolio 1
- Scizzotty2 Portfolio 1
- norms own
- chrismads Portfolio 1
- SUPRATRADE 1006071904
- bricker Portfolio 1
- iobound Portfolio 1
- PART 3 JPMorgan 26th Annual Healthcare Conf 1/8/08..2nd Day Reporting Companies..Nymph Take
- PART 5 JPMorgan 27th Annual Healthcare Conf 1/14/09..3rd Day Reporting Companies..Nymph Take
- News For Selected Stock
- Related stories on theStreet.com
- videos related to etf's
- No videos found
- blogs related to etf's
- No blogs found
Why I Love This Stock |
|
Date:12 30 08 |
|
7:30 |
|
Not yet rated
Rate now:
|
|
By:scdemjen |
Date:06 13 07 |
growth |
|
Not yet rated
Rate now:
|
|
By:Pro |
Date:11 30 -1 |
Downgraded by Maxim Group from Buy to Hold |
|
Not yet rated
Rate now:
|
|
By:Pro |
Date:11 30 -1 |
Downgraded by Bear Stearns from Outperform to Peer Perform |
|
Not yet rated
Rate now:
|
|
By:Pro |
Date:11 30 -1 |
Downgraded by Morgan Joseph from Buy to Hold |
|
Not yet rated
Rate now:
|
|
By:norm stevens |
Date:04 08 07 |
LOOKS GOOD |
|
Not yet rated
Rate now:
|
|
Date:12 10 06 |
|
Agree IDIX is a good speculative value. Added to my low priced portfolio. |
|
Not yet rated
Rate now:
|
|
By:tweakie |
Date:12 10 06 |
Why do the posting dates say 30th November 1999? |
|
Not yet rated
Rate now:
|
|
By:Randy Reese |
Date:11 30 -1 |
biopharm play |
|
Not yet rated
Rate now:
|
|
By:Guest |
Date:11 30 -1 |
Idenix Pharmaceuticals has partnered with Novartis on its drug, NM283. The drug has modest potency but is undergoing a trial in combination interferon and ribvirin that may show better results. Roche has a competing drug that may be more potent but it has to be given in higher doses. The trial for Idenix will hopefully clear things up. |
|
Not yet rated
Rate now:
|
|
Why I Hate This Stock |
|
By:LabRat |
Date:03 31 07 |
Pharma's really don't fit mainly because of high p/e's etc. Drug research is crucial yet I can't find one yet I really got to have. |
|
Not yet rated
Rate now:
|
|
